The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term results of the ADORE trial: Adjuvant oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX) versus 5-fluorouracil and leucovorin (FL) after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer.
 
Yong Sang Hong
No Relationships to Disclose
 
Sun Young Kim
No Relationships to Disclose
 
Ji Sung Lee
No Relationships to Disclose
 
Byung-Ho Nam
No Relationships to Disclose
 
Jeong Eun Kim
No Relationships to Disclose
 
Kyu-Pyo Kim
Travel, Accommodations, Expenses - Agios; Roche/Genentech; Roche/Genentech
 
Joon Oh Park
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene; Celgene; Celgene
Research Funding - AstraZeneca; Celgene
 
Young Suk Park
No Relationships to Disclose
 
Ji Yeon Baek
No Relationships to Disclose
 
Tae-You Kim
No Relationships to Disclose
 
Keun-Wook Lee
No Relationships to Disclose
 
Joong Bae Ahn
No Relationships to Disclose
 
Kyung Hae Jung
No Relationships to Disclose
 
Tae Won Kim
Employment - Asan Medical Center
Honoraria - AstraZeneca; Merck Serono